US Fertility Supplement Marketers Don’t Deliver
Executive Summary
FDA and FTC jointly warn five marketers of supplements with claims to treat fertility and other reproductive disorders. The unapproved and misbranded drugs could harm consumers and deter them from seeking effective treatments.
You may also be interested in...
From: US FDA; To: Supplement Industry – Tis The Season To Note Disease Claims, Undeclared Drugs
FDA wraps end-of-year greetings to supplement industry about drug-spiked products labeled as supplements in a bow with officials sharing annual update of their oversight of the industry during a food and drug regulation gathering.
US FDA Priorities For Food Safety, Cannabinoid Clear Even With Next Commissioner Unknown
FDA commissioner should be announced by mid-November and will likely continue to prioritize food and supplement safety, propelled by contaminants found in baby food, say two attorneys with Alston & Bird. A regulatory pathway for cannabidiol also is expected to be a priority once a commissioner is named.
Ruining The Mood, US FDA Says Glycerin, Oleate Cream Not Approved As OTC Contraceptive
Smart Women’s Choice promotes its namesake brand topicals with claims including “One hundred percent hormone-free, completely safe, natural birth control that cannot fail when used as directed and causes no harmful side effects,” FDA warning says.